Does the Relaxation Response Inhibit Acute Stress?
3 other identifiers
interventional
140
1 country
1
Brief Summary
The purposes of this study are:
- 1.To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
- 2.To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 healthy
Started May 2002
Longer than P75 for phase_2 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFebruary 16, 2017
February 1, 2017
9.4 years
September 13, 2005
February 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
Secondary Outcomes (1)
To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Interventions
Eligibility Criteria
You may qualify if:
- healthy individual
- age:18-49 years
- able to read and understand English
- able to attend al study visits
- access to a telephone (to schedule visits)
You may not qualify if:
- current smoking
- asthma
- current use of any prescription or psychoactive medications or supplements
- either:
- no prior experience with RR eliciting techniques
- at least 3 years of regular RR elicitation (at least 20 min/day)
- BMI \>30
- exhaled nitric oxide levels \>60 ppb
- abnormal lab values (Hct \<32,creatinine \>1.3, glucose \>200
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beth-Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Herbert Benson, MD
Beth Israel Deaconess Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Start
May 1, 2002
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
February 16, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share